Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07230028 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Doxycycline Boosted Therapy in Lyme Borreliosis: DoBo Study.

Study acronym: DoBo
StatusNot Yet Recruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 12 months later Nov 1, 2026 → Nov 1, 2027
See other at-risk trials from Radboud University Medical Center

Record History

  1. Notable Primary completion pushed from Nov 1, 2026 to Nov 1, 2027
    • Start date: Mar 1, 2026 to Mar 1, 2027
    • Study completion pushed from Nov 1, 2027 to Nov 1, 2028
    v2
  2. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this clinical trial is to learn if hydroxychloroquine works to treat long-term complaints attributed to Lyme borreliosis in adults. The main questions it aims to answer are: Does addition of hydroxychloroquine reduce physical complaints? Researchers will compare hydroxychloroquine to a placebo (a look-alike substance that contains no drug) to see if hydroxychloroquine works to treat Lyme borreliosis. Participants will: Take hydroxychloroquine or a placebo two times a day during 28 days. Visit the clinic 4 times in one year for checkups and tests.
Trial Details
NCT Number NCT07230028
Lead Sponsor Radboud University Medical Center
Collaborators: Ministerie van Volksgezondheid, Welzijn en Sport
Conditions
(from sponsor)
Lyme Borreliosis, Nervous System
Related terms Lyme Neuroborreliosis
Enrollment 50 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov